Next Generation Sequencing Congress 2010 15th & 16th November
Monday 15th November 2010 to Tuesday 16th November 2010 London, UK, - £650.00/person

Oxford Global Conference is proud to present the 2nd Annual Next Generation Sequencing (NGS) Congress, which will be held on the 15th & 16th November 2010 in London, UK. The congress is held in conjuction with our 2nd Anua qPCR Congress and our Analytical Genomics Congress
Next generation sequencing technologies are revolutioising biology by allowing for genome wide transcription factor binding-site profiling, transcriptome sequencing and more recently, as an endpoint to applications ranging fromchromatin immunoprecipitation, mutation mapping and polymorphism discovery to noncoding RNA discovery.
Over the 2 days, the conference provides an overview of the current options of next generation sequencing platform, technologies, applications and the newest computational tools for the analysis of next-generation sequencing data.
The three co-located events will attract over 350 senior-level decision makers working in bioinformatics & data management,next generation sequencing, discovery, RNA profiling, molecular genomics and clinical & diagnostics development from the UK, Europe and US. This prestigious event provides a forum for practitioners andresearchers to learn more about key solutions being provided to their industry, network with their peers, andaddress key industry concerns through a series of cutting edge conference presentations in a professional yet relaxed environment.
WHO YOU WILL MEET
Delegates are senior practitioners from major pharmaceutical, biotech companies as well as academic institutionsbased in UK and Europe and typically include VPs, Directors and Managers of: Drug Discovery, Next Generation Sequencing,Gene Expression, Epigenetics, Genomics, Sequencing Technology, ChIP Seq, Microarrays, High Throughput Technologies,Molecular Profiling/Diagnostics, Clinical Development, qPCR, Copy Number Variation, Principal Investigation,Bioinformatics, Data Management / Analysis, Biostatistics, Informatics, Semantics / Cloud Computing
Programme
Next Generation Sequencing Technologies and Data Management · High Throughput Sequencing Platforms: Implementation and Technology Considerations
· Next Generation Sequencing Technologies and Bioinformatics Analysis Tools
· NGS for Metagenomics
· Data Analysis, Data Management, LIMS, Storage Strategies · Cloud Computing / Semantic web
Next Generation Sequencing Applications · Sequencing Applications Considerations · Applying Next-Generation Sequencing to Cancer, Medical Genetics and Discovery Research · Epigenetics / DNA methylation · Personalised Medicine · Future perspectives
|
 |
 |
 |
| Hear insights and views from our leading line up of industry experts: |
 |
|
|
Jurg Bahler Professor of Cellular Systems Biology University College London
|
 |
|
|
Yu Hui Rogers Vice President, Core Technology Development and Services J.Craig Venter Institute
|
 |
|
|
David Dow, Group Leader, Molecular and Cellular Technologies, GlaxoSmithKline
|
 |
|
|
Andrew Feber, Medical Genomics, UCL Cancer Institute, University College London
|
 |
|
|
Juergan Kleffe, Institute for Molecular Biology and Bioinformatics, Berlin, Charite
|
 |
|
|
Kalim Mir, Wellcome Trust Fellow, Principle Investigator, The Wellcome Trust Centre for Human Genetics, University of Oxford
|
 |
|
|
Julian Parkhill, Director of Sequencing, Sanger Institute
|
 |
|
|
Gordon Brown Post-Doctoral Researcher Cancer Research UK Cambridge Research Institute
|
 |
|
|
Neil Gibson, Principal Scientist, Research and Development Genetics, AstraZeneca
|
 |
|
|
John Whittaker Director, Statistical Genetics GSK
|
 |
|
|
Peter Verhasselt Principal Scientist, Translational Genomics & Genetics Johnson & Johnson Pharmaceutical Research & Development
|
 |
|
|
Arjen Brinkman Department of Molecular Biology Nijmegen centre for Molecular Life Sciences
|
 |
|
|
Marc Peeters Department of Oncology University of Oxford
|
 |
|
|
Edward J. Oakeley Biomarker Development - Human Genetics and Genomics - Genome Technologies - Genome Sequencing Lab Novartis Institute for BioMedical Research
|
 |
|
|
Matthew Hall UK Team Leader, Computational Biology GSK
|
 |
|
|
Bhupinder Bhullar Lab Head, Development & Molecular Pathways Novartis
|
 |
|
|
Hendrik Marks, Post Doctural Research, Radbound University
|
 |
|
|
Richard Meehan Human Genetics Unit, Western General Hospital
|
 |
|
|
Bram Herman Agilent Technologies
|
 |
|
|
Mattias Prucha Partek
|
 |
|
|
Robert Nutter Life Technologies
|
 |
|
|
Mario Caccamo The Genome Analysis Centre
|
 |
|
|
Wigard Kloosterman University Medical Center Utrecht, Dept of Medical Genetics
|
 |
|
|
Klaas Zuideveld Roche NimbleGen, Inc
|
 |
|
|
Darrell Dinwiddie Post Doctoral Research Scientist National Centre for Genome Resources
|
 |
|
|
Katja Kobow Institute of Neuropathology
|
 |
|
|
Ryan Jacob DNASTAR
|
 |
|
|
Maria Moreno-Villanueva University of Konstanz
|
 |
|
|
Kristina Warton Ovaarian Cancer Group, Gavan
|
 |
|
|
Fatemeh G Haghighi New York State Psychiatric Institute
|
 |
|
|
Steve Laval Newcastle University
|
 |
|
|
Tomas Babak Senior Research Scientist, Molecular Profiling and Research Informatics Merck Inc
|
 |
|
|
Frederic Raymond Microarray Facility Manager Nestle Research Center, Switzerland
|
 |
|
|
Elaine Sanij Peter MacCallum Cancer Centre
|
 |
|
 |
 |
 |
|
|
|